Zobrazeno 1 - 10
of 239
pro vyhledávání: '"de Leng, WWJ"'
Autor:
Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Battaglia TW; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Berge Henegouwen JM; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands., de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van der Wijngaart H; Department of Medical Oncology, Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands., van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Chalabi M; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Devriese LA; Division Beeld & Oncologie, Department of Medical Oncology, Utrecht University Medical Center, Utrecht, the Netherlands., Erdkamp FLG; Department of Medical Oncology, Zuyderland Hospital, Sittard-Geleen, the Netherlands., Labots M; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands., de Jonge MJA; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Kerver ED; Department of Medical Oncology, OLVG, Amsterdam, the Netherlands., Bins AD; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands., Leek LVM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Notohardjo JCL; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam University Medical Center, location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands., Wessels LFA; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van de Haar J; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 01; Vol. 30 (19), pp. 4339-4351.
Autor:
Geurts BS; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zeverijn LJ; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Leek LVM; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Berge Henegouwen JM; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands., Hoes LR; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van der Wijngaart H; Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands., van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands., van de Haar J; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Ommen-Nijhof A; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok M; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands., Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands., de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, the Netherlands., de Jonge MJA; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Hoeben A; Department of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands., van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., Wessels LFA; Oncode Institute, Utrecht, the Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Voest EE; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 03; Vol. 30 (17), pp. 3735-3746.
Autor:
Ebbelaar CF; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: c.f.ebbelaar@lumc.nl., van Dijk M; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Breimer GE; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Meijers RWJ; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Klein LBC; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Petronilia MM; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., de Leng WWJ; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Blokx WAM; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Jansen AML; Department of Pathology, Division of Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Aug; Vol. 37 (8), pp. 100538. Date of Electronic Publication: 2024 Jun 14.
Autor:
Priesterbach-Ackley LP; Department of Pathology, University Medical Center Utrecht, Internal Mail No. H04.312, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands., Cordier F; Department of Pathology, University Medical Center Utrecht, Internal Mail No. H04.312, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands.; Department of Pathology, Ghent University Hospital, Ghent, Belgium., de Witt Hamer P; Department of Neurosurgery, Amsterdam University Medical Centers/VUmc and Brain Tumor Center, Amsterdam, The Netherlands., Snijders TJ; Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, Utrecht, The Netherlands., Robe PA; Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, Utrecht, The Netherlands., Küsters B; Department of Pathology, Radboudumc, Nijmegen, The Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Internal Mail No. H04.312, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands., den Dunnen WFA; Department of Pathology, University Medical Center Groningen, Groningen, The Netherlands., Brandsma D; Department of Neuro-Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Jansen C; Laboratory for Pathology Eastern Netherlands, LABPON, Hengelo, The Netherlands., Wesseling P; Department of Pathology, Amsterdam University Medical Centers/VUmc and Brain Tumor Center Amsterdam, and Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Muhlebner A; Department of Pathology, University Medical Center Utrecht, Internal Mail No. H04.312, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. a.muhlebner@umcutrecht.nl.
Publikováno v:
Acta neuropathologica [Acta Neuropathol] 2024 Jul 29; Vol. 148 (1), pp. 12. Date of Electronic Publication: 2024 Jul 29.
Autor:
Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands., Geurts BS; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Zeverijn LJ; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Wit GF; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands., de Leng WWJ; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands., Jansen AML; Department of Pathology, University Medical Cancer Center Utrecht, Utrecht, The Netherlands., Kusters B; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Beerepoot LV; Department of Internal Medicine, ETZ Hospital (Elisabeth-TweeSteden Ziekenhuis), Tilburg, The Netherlands., de Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., de Groot DA; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands., de Groot JWB; Isala Oncology Center, Isala, Zwolle, The Netherlands., Hoeben A; Division of Medical Oncology, Department of Internal Medicine, GROW School of Oncology and Development Biology, Maastricht University Center+, Maastricht, The Netherlands., Buter J; Department of Medical Oncology, Amsterdam University Medical Center, Location VuMC, Amsterdam, The Netherlands., Gelderblom HAJ; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Voest EE; Oncode Institute, Utrecht, The Netherlands.; Department of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam,The Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
Publikováno v:
The oncologist [Oncologist] 2024 May 03; Vol. 29 (5), pp. 431-440.
Autor:
Spiekman IAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands., Zeverijn LJ; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Geurts BS; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Verkerk K; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Haj Mohammad SF; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Jansen AML; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Gootjes EC; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., de Groot DA; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Kerver ED; Department of Medical Oncology, OLVG, Amsterdam, the Netherlands., van Voorthuizen T; Department of Medical Oncology, Rijnstate, Arnhem, the Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Valkenburg-van Iersel LBJ; Division of Medical Oncology, Department of Internal Medicine, GROW school of Oncology and Development Biology, Maastricht University Center+, Maastricht, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Voest EE; Oncode Institute, Utrecht, the Netherlands; Department of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands. Electronic address: h.verheul@erasmusmc.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113988. Date of Electronic Publication: 2024 Mar 07.
Autor:
van Opijnen MP; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands. m.p.van_opijnen@lumc.nl.; Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands. m.p.van_opijnen@lumc.nl., Broekman MLD; Department of Neurosurgery, Haaglanden Medical Center, The Hague, The Netherlands.; Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands., Cuppen E; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands., Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Ter Elst A; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., van Eijk R; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Mühlebner A; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Jansen C; Laboratorium Pathologie Oost-Nederland, Hengelo, The Netherlands., van der Geize R; Laboratorium Pathologie Oost-Nederland, Hengelo, The Netherlands., Speel EM; Department of Pathology, GROW-School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands., Groenen PJTA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., de Vos FYF; Department of Medical Oncology, Utrecht University Medical Center, Utrecht, The Netherlands., Wesseling P; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Maas SLN; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2024 Feb; Vol. 166 (3), pp. 485-492. Date of Electronic Publication: 2024 Jan 29.
Autor:
Priesterbach-Ackley LP; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., van Kuik J; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Tops BBJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Lasorella A; Department of Biochemistry and Molecular Biology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA., Iavarone A; Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, Florida, USA., van Hecke W; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Robe PA; Department of Neurosurgery, University Medical Center Utrecht, Utrecht, The Netherlands., Wesseling P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pathology, Amsterdam University Medical Centers/VUmc & Brain Tumor Center Amsterdam, Amsterdam, The Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
Neuro-oncology practice [Neurooncol Pract] 2024 Jan 05; Vol. 11 (2), pp. 142-149. Date of Electronic Publication: 2024 Jan 05 (Print Publication: 2024).
Autor:
van Garderen KA; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Medical Delta, Delft, The Netherlands., Vallentgoed WR; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., Lavrova A; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands., Niers JM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Leng WWJ; Department of Pathology, UMC Utrecht, Utrecht, The Netherlands., Hoogstrate Y; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., de Heer I; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., Ylstra B; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van Dijk E; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Klein S; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands., Draaisma K; Department of Neurosurgery, UMC Utrecht, The Netherlands., Robe PAJT; Department of Neurosurgery, UMC Utrecht, The Netherlands., Verhaak RGW; Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; Department of Neurosurgery, Amsterdam UMC, Amsterdam, The Netherlands., Westerman BA; Department of Neurosurgery, Amsterdam UMC, Amsterdam, The Netherlands., French PJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., van den Bent MJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., Kouwenhoven MCM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Kros JM; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands., Wesseling P; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Smits M; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Medical Delta, Delft, The Netherlands.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2023 Nov 09; Vol. 5 (1), pp. vdad149. Date of Electronic Publication: 2023 Nov 09 (Print Publication: 2023).
Autor:
Stelloo E; Cergentis BV, Utrecht, the Netherlands., Meijers RWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Swennenhuis JF; Cergentis BV, Utrecht, the Netherlands., Allahyar A; Oncode Institute, Hubrecht Institute-Royal Netherlands Academy of Arts and Sciences, and University Medical Center Utrecht, Utrecht, the Netherlands., Hajo K; Cergentis BV, Utrecht, the Netherlands., Cangiano M; Cergentis BV, Utrecht, the Netherlands., de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., van Helvert S; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Van der Meulen J; Molecular Diagnostics, Ghent University Hospital, Ghent, Belgium., Creytens D; Department of Pathology, Ghent University Hospital, Ghent, Belgium., van Kempen LC; Department of Pathology, University Hospital Antwerp, University of Antwerp, Antwerp, Belgium; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Cleton-Jansen AM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., de Laat W; Oncode Institute, Hubrecht Institute-Royal Netherlands Academy of Arts and Sciences, and University Medical Center Utrecht, Utrecht, the Netherlands., Splinter E; Cergentis BV, Utrecht, the Netherlands., Feitsma H; Cergentis BV, Utrecht, the Netherlands. Electronic address: harma.feitsma@cergentis.com.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2023 Oct; Vol. 25 (10), pp. 758-770. Date of Electronic Publication: 2023 Jul 28.